Cornell Pochily Investment Advisors Inc. Has $202,000 Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Cornell Pochily Investment Advisors Inc. reduced its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 5.3% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,046 shares of the exchange traded fund’s stock after selling 115 shares during the period. Cornell Pochily Investment Advisors Inc.’s holdings in SPDR S&P Biotech ETF were worth $202,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Creative Planning boosted its position in SPDR S&P Biotech ETF by 15.6% in the third quarter. Creative Planning now owns 29,114 shares of the exchange traded fund’s stock valued at $2,876,000 after buying an additional 3,920 shares in the last quarter. Fiduciary Alliance LLC lifted its stake in shares of SPDR S&P Biotech ETF by 2.8% in the 3rd quarter. Fiduciary Alliance LLC now owns 23,966 shares of the exchange traded fund’s stock valued at $2,368,000 after acquiring an additional 648 shares during the last quarter. ORG Wealth Partners LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the 3rd quarter valued at $44,000. Shaker Investments LLC OH grew its position in SPDR S&P Biotech ETF by 63.5% during the 3rd quarter. Shaker Investments LLC OH now owns 9,575 shares of the exchange traded fund’s stock worth $946,000 after acquiring an additional 3,720 shares during the last quarter. Finally, Carnegie Investment Counsel increased its holdings in SPDR S&P Biotech ETF by 3.2% in the 3rd quarter. Carnegie Investment Counsel now owns 95,423 shares of the exchange traded fund’s stock worth $9,428,000 after purchasing an additional 2,975 shares in the last quarter.

SPDR S&P Biotech ETF Trading Up 0.4 %

SPDR S&P Biotech ETF stock opened at $99.07 on Tuesday. The company has a market capitalization of $7.55 billion, a PE ratio of 11.47 and a beta of 1.11. The stock has a 50-day moving average price of $98.65 and a two-hundred day moving average price of $94.20. SPDR S&P Biotech ETF has a 12 month low of $63.80 and a 12 month high of $103.52.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.